Key Blood Screening Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The global market is extremely dominated by key players, including Grifols, Abbott, and Roche, all of which jointly account for a generous global share, through NAT automation and leadership. Besides, AI-powered investments, emerging economies, and pathogen inactivation technology are a few strategies that are readily adopted by all these organizations. Through effective investments, Roche successfully reduced false positives, followed by Abbott offering NAT test services in India, with the pathogen inactivation by Grifols, there has been capturing of the majority of the Europe-based plasma market, thus suitable for the overall market’s growth.
Here is a list of key players operating in the global market:
|
Company Name (Country) |
Industry Focus |
Market Share |
|
Roche Diagnostics (Switzerland) |
Leading NAT & ELISA kits (cobas MPX), automated blood screening systems. |
27.2% |
|
Abbott Laboratories (U.S.) |
ARCHITECT NAT assays, blood bank automation, HIV/HCV/HBV detection. |
18.3% |
|
Grifols (Spain) |
Plasma screening (Procleix), pathogen reduction tech (INTERCEPT). |
16.5% |
|
Bio-Rad Laboratories (U.S.) |
ELISA kits (BioPlex), Western blot confirmatory tests. |
13.2% |
|
Thermo Fisher Scientific (U.S.) |
NAT reagents, automated platforms (TaqPath), high-throughput screening. |
10.5% |
|
Siemens Healthineers (Germany) |
ADVIA Centaur immunoassays, blood bank software solutions. |
xx% |
|
Becton Dickinson (BD) (U.S.) |
FACS cell analyzers, blood culture systems. |
xx% |
|
Ortho Clinical Diagnostics (U.S.) |
Vitros NAT, blood typing, transfusion diagnostics. |
xx% |
|
Hologic (U.S.) |
Panther NAT systems, HPV/blood donor screening. |
xx% |
|
QuidelOrtho (U.S.) |
Rapid tests (Sofia), point-of-care blood screening. |
xx% |
|
Danaher (U.S.) |
Beckman Coulter analyzers, hematology testing. |
xx% |
|
BioMérieux (France) |
VIDAS ELISA, bacterial blood culture detection. |
xx% |
|
TransAsia Bio-Medicals (India) |
ELISA kits, rapid tests for HIV/HBV/HCV. |
xx% |
|
SD Biosensor (South Korea) |
STANDARD NAT assays, point-of-care rapid tests. |
xx% |
|
Werfen (Spain) |
Hemostasis testing (HemosIL), specialized coagulation analyzers |
xx% |
Sources: Roche, Abbott, Grifols, Bio-Rad, Thermo Fisher, Siemens Healthineers, BD, Ortho Clinical, Hologic, QuidelOrtho, Danaher, BioMérieux, TransAsia, SD Biosensor, Werfen, Sysmex, Toshiba Medical Systems, Fujirebio, LSI Medience, Eiken Chemical
Below are the areas covered for each company in the blood screening market:
